HomeGLSI • NASDAQ
add
Greenwich Lifesciences Inc
Previous close
$14.20
Day range
$13.19 - $14.19
Year range
$7.58 - $21.44
Market cap
177.85M USD
Avg Volume
36.95K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 2.66M | 52.27% |
Net income | -2.61M | -60.08% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -2.66M | -52.30% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 7.22M | -33.98% |
Total assets | 7.23M | -34.00% |
Total liabilities | 1.35M | 348.70% |
Total equity | 5.88M | — |
Shares outstanding | 13.14M | — |
Price to book | 31.56 | — |
Return on assets | -104.46% | — |
Return on capital | -121.01% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -2.61M | -60.08% |
Cash from operations | -1.05M | -8.36% |
Cash from investing | — | — |
Cash from financing | 2.77M | — |
Net change in cash | 1.72M | 277.76% |
Free cash flow | -699.06K | 31.83% |
About
Founded
2006
Headquarters
Website
Employees
3